Madrigal Pharmaceuticals (MDGL) Expected to Post Quarterly Earnings on Tuesday
Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) is projected to post its Q3 2026 results before the market opens on Tuesday, November 3rd. Analysts expect the company to announce earnings of ($0.8629) per share and revenue of $404.17 million for the quarter. Parties can check the company’s upcoming Q3 2026 earnings report for the latest […]
27 Oct 09:44 · The Cerbat Gem